Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: During the first and second COVID-19 pandemic waves, children, despite susceptible to SARS-CoV-2 infection, appeared at lower risk of severe disease, hospitalization, and death than adults and the elderly. Moreover, they seemed to play a minor role in the diffusion of the virus. The aim of this manuscript is to show epidemiological surveillance on COVID-19 incidence and hospitalization in the pediatric cohort in order to explain the importance of an adequate COVID-19 vaccination coverage in the pediatric population.

Methods: All subjects with documented SARS-CoV-2 infection diagnosed in Parma, Italy, between February 21st, 2020, and January, 31st, 2022, were recruited in this epidemiological surveillance. Diagnosis of infection was established in presence of at least one respiratory specimen positive for SARS-CoV-2 nucleic acid using a validated real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay.

Results: The number of COVID-19 pediatric cases remained very low and lower than that recorded in the general population between early February 2020 and the end of October 2021, despite in the last part of this period the Delta variant emerged. On the contrary, starting from November 2021, a sharp and significant increase in COVID-19 incidence in the pediatric population was evidenced. This was detected in all the age groups, although greater in the populations aged 5-11 and 12-17 years old. Interestingly, the peak in hospitalization rate was observed in children < 5 years old, for whom COVID-19 vaccination is not approved yet. At the beginning of November 2021 among people older than 18 years of age 85.7% had completed the primary series of COVID-19 vaccine. Almost all the infants and pre-school children were susceptible. Until January 31st, 2022, 80.4% of adolescents aged 11-17 years had received at least two doses of COVID-19 vaccine and only 52.4% received the booster. Among children 5-11 years old, on January 31st, 2022, only 28.5% had received at least one vaccine dose.

Conclusions: Compared with adults and the elderly, presently a greater proportion of children and adolescents is susceptible to SARS-CoV-2 and could play a relevant role for the prolongation of the COVID-19 pandemic. Only a rapid increase in vaccination coverage of the pediatric populations can effectively counter this problem.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389475PMC
http://dx.doi.org/10.1186/s13052-022-01339-xDOI Listing

Publication Analysis

Top Keywords

vaccination coverage
8
coverage pediatric
8
sars-cov-2 infection
8
epidemiological surveillance
8
covid-19 incidence
8
pediatric
5
covid-19
5
covid pandemic
4
pandemic adequate
4
adequate vaccination
4

Similar Publications

Deduplication of temporary names in an immunization registry using probabilistic linkage.

Vaccine

September 2025

Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, MI, United States of America.

Context: Records with temporary names, such as Babygirl, BoyA, etc. are sometimes submitted to immunization information systems (IIS) with vaccinations that are administered before the child has a legal name.

Objectives: To 1) apply probabilistic record linkage to assist in the deduplication of children with temporary names in an IIS and 2) assess the impact of that deduplication on vaccination coverage rates.

View Article and Find Full Text PDF

Despite the therapeutic potential of the primary vaccine series, a lack of confidence in the COVID-19 booster vaccine poses a threat to public health and undermines its coverage at the national, regional, and global levels. This study aimed to understand COVID-19 booster vaccine confidence (CBVC) among Bangladeshi adults aged 18-49 and the potential predictors of CBVC. In line with STROBE guidelines, a face-to-face cross-sectional survey was conducted from June 15 to August 31, 2023 during the spread of the SARS-CoV-2 Omicron variant.

View Article and Find Full Text PDF

Influenza vaccination coverage assessments by race and ethnicity can identify populations less protected from influenza morbidity and mortality and help focus vaccination efforts. Across eight Vaccine Safety Datalink health systems, we identified influenza vaccines administered from August 1 through March 31 each season from 2017 to 18 through 2022-23 using electronic health records linked to immunization registries. We calculated crude vaccination coverage for each season among people in five age groups (6 months-8 years, 9-17, 18-49, 50-64, and ≥ 65 years) by self-reported race and ethnicity.

View Article and Find Full Text PDF

Background: Limited mpox vaccination coverage, declining cross-protection from historical smallpox vaccination campaigns, and persistent zoonotic reservoirs leave many sub-Saharan countries susceptible to mpox outbreaks. With millions of vaccine doses made available to the region since late 2024 and the absence of country-specific guidelines for allocation, estimating the country-specific impact of one-time mass vaccination strategies is necessary for ongoing outbreaks and other countries at future risk.

Methods And Findings: We adapted a next generation matrix model to project disease transmission potential for 47 sub-Saharan countries from 2025 to 2050 under four transmission scenarios with different contributions of community versus sexual contacts.

View Article and Find Full Text PDF

To evaluate progress toward MTCT elimination of HBV, we analyzed 8-y trends in hepatitis B vaccine (HepB) and hepatitis B immune globulin (HBIG) administration coverage rates in Shandong province, focusing on high-risk populations. Data were collected from a provincial system, Shandong Vaccination Information System. Information of maternal HBsAg+ neonates born in 2017-2024 were extracted.

View Article and Find Full Text PDF